drugset / Trial / NCT00538967

The Effect of Doxycycline on Matrix Metalloproteinase Expression and Activity in the Abdominal Aneurysm

NCT00538967

Phase 2 Completed 60 enrolled Leiden University Medical Center
RandomizedParallel-groupSingle-blindBasic science

Summary

The matrix metalloproteinase-9 (MMP-9) is considered to play a central role in abdominal aortic aneurysm (AAA) initiation. Doxycycline has direct MMP-9 inhibiting properties in vitro, and it effectively suppresses AAA development in rodents. Observed inhibition of AAA progression, and contradictory findings in human studies evaluating the effect of doxycycline therapy on aortic wall MMP-9 suggest that the effects of doxycycline extend beyond MMP-9 inhibition, and that the effect may be dose dependent.

Timeline

Start
2002-05
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxycycline Small molecule 50 mg
Comparator Doxycycline Small molecule 100 mg
Comparator Doxycycline Small molecule 300 mg